remdesivir

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients

Multicenter, Retrospective Study of the Effects of Remdesivir in the Treatment of Severe Covid-19 Infections

Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals

An Open-label, Clinical Feasibility Study of the Efficacy of Remdesivir for Long-COVID.

Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)

ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19

Remdesivir for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)

Safety, Pharmacokinetics, and Antiviral Activity of Remdesivir (VEKLURY®) in Hospitalized Children With RSV

SARS-CoV-2 Human Challenge Characterisation Study

A Study of CX2101A Enteric-Coated Tablets in Healthy Chinese Adult Subjects

Trial to Determine the Efficacy/Safety of Plitidepsin vs Control in Patients With Moderate COVID-19 Infection

AZD7442 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Antiviral Strategies in the Prevention of Long-term Cardiovascular Outcomes Following COVID-19: The paxloviD/Remdesivir Effectiveness For the prEvention of loNg coviD Clinical Trial

Study to Evaluate the Clinical Outcomes in Adults With Covid-19 Who Have Been Treated With Remdesivir.

An International Randomized Trial of Additional Treatments for COVID-19 in Hospitalized Patients Who Are All Receiving the Local Standard of Care - WHO-SOLIDARITY-GERMANY

Trial of Treatments for COVID-19 in Hospitalized Adults

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

Australasian COVID-19 Trial (ASCOT) ADAptive Platform Trial